Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Child Adolesc Psychopharmacol ; 34(2): 89-94, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38483960

RESUMEN

Background: Previous studies suggest that selective serotonin reuptake inhibitors (SSRIs) may increase the risk of suicide among children and youth, although the association between suicide risk and the combination of SSRIs with other medication such as stimulants in this population remains unclear. This study explored whether the combination of SSRIs with stimulants influenced suicide risk. Methods: A retrospective cohort study was conducted at a single children's hospital campus-based ambulatory psychiatric clinic between September 1, 2017, and September 30, 2020. Subjects were 6-21 years of age and prescribed either stimulants or stimulants and SSRIs only. The primary outcome was suicidal thoughts and behaviors (STB), defined by documented suicidal thoughts, plans, or behaviors. Firth logistic regression evaluated associations between medication class and STB. Results: Among 349 patients, the prevalence of STB was 5.7% (n = 20). In unadjusted model, patients prescribed SSRIs and stimulants had a 2.9-fold increase of STB compared to patients prescribed stimulants only, along with increasing age, male sex, and the diagnoses of anxiety and/or depression. In the final model adjusted for each of these factors, the observed association of medication regiment with STB was attenuated (odds ratio [OR]: 1.3, confidence interval [CI]: 0.3-4.9, p = 0.7). The magnitude of the adjusted association between depressive diagnosis and STB was notable (OR: 3.6, CI: 1.0-12.6, p = 0.049). Conclusions: Among patients followed in a children's hospital-based ambulatory psychiatric clinic, a combination medication regimen of SSRIs and stimulants after adjusting for genetic sex, age, anxiety diagnosis, and depression diagnosis, the observed association between STB and combination stimulant and SSRI treatment was attenuated. This finding suggests that other factors, including depression, may have contributed to the association between SSRI treatment and STB. Larger, prospective studies of the relationship between combination pharmacotherapy and suicide risk are warranted to guide clinical/pharmacological decision making and to better clarify these relationships.


Asunto(s)
Estimulantes del Sistema Nervioso Central , Suicidio , Niño , Adolescente , Humanos , Masculino , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos , Estudios Retrospectivos , Estudios Prospectivos , Estimulantes del Sistema Nervioso Central/efectos adversos
2.
Child Psychiatry Hum Dev ; 50(1): 27-34, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-29855820

RESUMEN

Given the high rates of comorbid anxiety and autism spectrum disorder (ASD) in the adolescent and young adult population, effective treatment protocols to address anxiety symptoms are of importance to help promote greater independence across settings. While research supports the use of cognitive-behavioral therapy (CBT) across younger age groups with ASD, the literature is limited on interventions benefitting adolescents and young adults with comorbid anxiety disorders and ASD. Therefore, this open trial utilized a modified CBT manual for seven participants between the ages of 16 and 20 years, consisting of a 16-week modularized CBT treatment, including psychoeducation, cognitive therapy, and exposure therapy. Measures of anxiety and depression were completed at baseline and post-treatment. Findings demonstrated significant reductions on clinician-rated measures of anxiety. While findings are encouraging, additional studies examining the efficacy of CBT for this population with ASD and clinical anxiety are necessary to further identify beneficial treatment components.


Asunto(s)
Trastornos de Ansiedad , Ansiedad , Trastorno del Espectro Autista , Terapia Cognitivo-Conductual/métodos , Adolescente , Ansiedad/diagnóstico , Ansiedad/etiología , Ansiedad/terapia , Trastornos de Ansiedad/epidemiología , Trastornos de Ansiedad/psicología , Trastornos de Ansiedad/terapia , Trastorno del Espectro Autista/epidemiología , Trastorno del Espectro Autista/psicología , Trastorno del Espectro Autista/terapia , Comorbilidad , Depresión/diagnóstico , Depresión/etiología , Depresión/terapia , Femenino , Humanos , Terapia Implosiva/métodos , Masculino , Técnicas Psicológicas , Resultado del Tratamiento , Estados Unidos , Adulto Joven
3.
J Child Adolesc Psychopharmacol ; 27(1): 10-18, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27128785

RESUMEN

OBJECTIVE: The purpose of this article is to review the literature on hypothesized behavioral correlates of pharmacotherapy treatment response. A particular focus is placed on what have been referred to as "common factors" across mental health treatments, including medication adherence, therapeutic alliance, motivation for behavior change, and expectancies for positive treatment outcomes. These understudied factors may provide unique explanations for mechanisms of symptom change, patient risk as a result of protocol deviation, and attenuated treatment outcomes. METHOD: A literature search was conducted to evaluate the relationship between treatment processes in pediatric psychiatry and medication adherence, therapeutic alliance, motivation for behavior change, and expectancies for positive treatment outcomes. RESULTS: Substantial variability and room for improvement was identified for each common factor. Behavioral protocols have already been developed to address many aspects of common factors in pediatric psychiatric treatment, but are not yet a part of many practice parameters. CONCLUSION: Interventions to improve common factors can be used immediately in tandem with psychopharmacological interventions to provide increased symptom relief and reduce patient risk. Furthermore, incorporating instruction in common factors interventions can positively affect training of future providers and enhance understanding of the mechanisms of effect of medications. An increased focus on common factors, with a particular emphasis on quantifying the magnitude and mechanisms of their effects on psychopharmacological interventions stand to benefit child patients, their families, treatment providers, training facilities, and pharmaceutical manufacturers.


Asunto(s)
Cumplimiento de la Medicación , Trastornos Mentales/tratamiento farmacológico , Psicotrópicos/uso terapéutico , Niño , Psiquiatría Infantil , Humanos , Trastornos Mentales/fisiopatología , Trastornos Mentales/psicología , Motivación , Relaciones Profesional-Paciente , Psicotrópicos/administración & dosificación , Resultado del Tratamiento
4.
J Atten Disord ; 20(7): 617-26, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-22923782

RESUMEN

OBJECTIVE: Although evidence suggests that hoarding may be associated with symptoms of ADHD, no study has examined this relationship in children. METHOD: Participants included 99 youth diagnosed with ADHD (and a parent) seen in a general outpatient psychiatry clinic. Children completed the Obsessive-Compulsive Inventory-Child Version, the Revised Child Anxiety and Depression Scale, and the Rosenberg Self-Esteem Scale. Parents completed the Children's Saving Inventory and Vanderbilt ADHD Diagnostic Rating Scale-Parent Version. RESULTS: Inattentive and hyperactive/impulsive symptoms were the only indicator that differentiated those with and without clinically significant hoarding. Symptoms of ADHD, but not nonhoarding obsessive-compulsive symptoms, significantly predicted hoarding. Inattention and hyperactivity/impulsivity were uniquely associated with individual hoarding features. Hoarding symptoms mediated the relationship between ADHD and oppositionality. CONCLUSION: These findings contribute to the growing literature about the association between hoarding and ADHD.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/psicología , Acaparamiento/etiología , Adolescente , Trastornos de Ansiedad/etiología , Niño , Femenino , Humanos , Hipercinesia/psicología , Conducta Impulsiva/fisiología , Masculino , Padres , Escalas de Valoración Psiquiátrica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA